You searched for "breathing"
Communication in the age of universal masking: speech-to-text apps to the rescue
The ongoing COVID-19 pandemic has touched nearly every aspect of our lives, including how we interact with patients. At this point, it is almost hard to remember a time when we didn’t have to wear masks during clinical encounters. Though...Did you ever meet Draffin on your travels?
Draffin’s rods or bipods are a well-known ENT instrument. Before their invention in 1951, the attendant anaesthetist or nurse was obliged to support the mouthgag during tonsillectomy. Their originator, David Alexander Draffin (born in 1917 in Ballybey, Co Monaghan), was...ENT in this issue...FESS - The Stammberger Legacy (May/Jun19)
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK E: d.costello@nhs.net Claire Hopkins, FRCS(ORLHNS) DM (Oxon),Guy’s and St Thomas’ Hospitals, London; Professor of Rhinology, King’s College London, UK....Subjective tinnitus – adding mutebutton™ to your tinnitus toolbox
Neurophysiologic tinnitus or subjective tinnitus is typically a sound or a number of sounds that originate from the auditory nervous system. They are unwanted sounds that do not exist in the external environment. They can be heard in one or...Could OtoRecall transform ENT learning?
Training continues to change and evolve in the face of changing working practices and, of course, the impact of unprecedented events like the pandemic. The basics remain important for safe practice as training and work continue to evolve; innovative tools...Lawrence Werth (19 October 1956 – 19 August 2014)
In August the audiology community was saddened to learn that Lawrence Werth (57), Chairman of PC Werth Ltd, London had passed away after a brave battle with skin cancer. A prolific contributor to this magazine over the years, he is...
Drug eluting stent vs INCS for CRS
A prospective, randomised study from Finland to compare a drug eluting stent (DES) and intranasal corticosteroids (INCS) in 63 patients as assessed by SNOT-22, VAS, endoscopy, CT and rhinometry pre-treatment, at three and six months post treatment. Recruitment was over...
CRSwNP, another monoclonal antibody
Interleukins 4, 5 and 13 were shown to be important factors in type 2 inflammation, which characterises chronic rhinosinusitis with nasal polyposis (CRSwNP). In CRSwNP non-responders and those who recur short after-surgery monoclonal antibodies might be an answer. Examples include...
When should revision FESS leave you reaching for the script pad?
This very interesting work from the professorial team in London seeks to define a group of patients with CRSwNP who may benefit from early biological treatment since they are at risk of failure of surgical and conventional medical management. Approximately...
